XML 35 R28.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity Plans and Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Option Activity under Stock-Based Compensation Plans

The following table summarizes the activity of stock options for the three months ended March 31, 2024:

 

 

 

Shares
Underlying
Outstanding
Options
(in thousands)

 

 

Weighted-
Average
Exercise
Price Per Share

 

 

Weighted-
Average
Remaining
Contractual
Term (years)

 

 

Aggregate
Intrinsic
Value (in thousands)

 

Balance as of December 31, 2023

 

 

10,120

 

 

$

10.78

 

 

 

4.18

 

 

$

37,388

 

Options granted

 

 

1,505

 

 

 

12.46

 

 

 

 

 

 

 

Options exercised

 

 

(240

)

 

 

6.82

 

 

 

 

 

 

 

Options cancelled:

 

 

 

 

 

 

 

 

 

 

 

 

Options forfeited (unvested)

 

 

(2

)

 

 

9.52

 

 

 

 

 

 

 

Options expired (vested)

 

 

(89

)

 

 

15.46

 

 

 

 

 

 

 

Balance as of March 31, 2024

 

 

11,294

 

 

$

11.05

 

 

 

4.39

 

 

$

23,032

 

Vested and expected to vest as of March 31, 2024

 

 

11,050

 

 

$

11.03

 

 

 

4.35

 

 

$

22,954

 

Exercisable as of March 31, 2024

 

 

7,653

 

 

$

10.56

 

 

 

3.59

 

 

$

20,912

 

Summary of Restricted Stock Units Activity

The following table summarizes the activity of RSUs for the three months ended March 31, 2024:

 

 

 

Number of Shares
(in thousands)

 

 

Weighted-Average
Grant-Date Fair
Value Per Share

 

Non-vested as of December 31, 2023

 

 

4,445

 

 

$

11.57

 

Granted

 

 

2,962

 

 

 

12.49

 

Vested (1)

 

 

(1,637

)

 

 

11.11

 

Forfeited

 

 

(54

)

 

 

12.91

 

Non-vested as of March 31, 2024

 

 

5,716

 

 

$

12.16

 

Summary Of Performance Based Restricted Stock Unit

We granted market-based performance restricted stock units (“PSUs”) to certain executives. These PSUs vest upon a specified market condition. The summary of PSU activities for the three months ended March 31, 2024 is as follows:

 

 

 

Number of Shares
(in thousands)

 

 

Weighted-Average
Grant-Date Fair
Value Per Share

 

Non-vested as of December 31, 2023

 

 

557

 

 

$

15.95

 

Granted

 

 

558

 

 

 

17.23

 

Non-vested as of March 31, 2024

 

 

1,115

 

 

$

16.59

 

Fair Value-Based Measurements and Weighted-Average Assumptions The weighted-average assumptions used in the calculations of these fair value measurements are as follows:

 

 

 

Stock Options

 

 

 

Market-Based Performance Stock Units

 

 

 

Three Months Ended

 

 

 

Three Months Ended

 

 

March 31,

 

 

 

March 31,

 

 

2024

 

 

2023

 

 

 

2024

 

 

2023

 

Weighted-average fair value per share

 

$

7.88

 

 

$

7.28

 

 

 

$

17.23

 

 

$

18.25

 

Risk-free interest rate

 

 

4.2

%

 

 

4.0

%

 

 

 

4.3

%

 

 

4.3

%

Expected life (in years)

 

 

4.5

 

 

 

4.5

 

 

 

 

2.9

 

 

 

2.9

 

Volatility

 

 

0.8

 

 

 

0.8

 

 

 

 

0.6

 

 

 

0.9

 

Stock-Based Compensation Expense

The following table summarizes stock-based compensation expense recorded in each component of operating expenses in our condensed consolidated statements of operations, and amounts capitalized to our inventories (in thousands):

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2024

 

 

2023

 

 

Research and development

 

$

2,665

 

 

$

2,112

 

 

Selling, general and administrative

 

 

8,920

 

 

 

6,830

 

 

Cost of sales - product

 

 

559

 

 

 

695

 

 

Inventories

 

 

870

 

 

 

397

 

 

Total

 

$

13,014

 

 

$

10,034